SaintMed マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Viroje Vasusuttikulkant

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	8.5%
経営陣の平均在職期間	2.6yrs
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

CEO（最高経営責任者

Viroje Vasusuttikulkant

no data

在職期間

Dr. Viroje Vasusuttikulkant serves as Chief Executive Officer and Director at Saintmed Public Company Limited and served as its Acting Chief Financial Officer since April 1, 2022 until April 8, 2022.

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Viroje Vasusuttikulkant	CEO & Director	no data	データなし	8.52% THB 102.6m
Prapassorn Patamapinun	Chief Financial Officer	2.6yrs	データなし	データなし
Sorajja Boonprasit	COO & Director	no data	データなし	12.07% THB 145.4m
Chonchanok Sumrongkij	Accounting Manager	1.5yrs	データなし	データなし
Rhamon Vasusuttikulkant	Chief Sales and Marketing Officer	2.6yrs	データなし	9.83% THB 118.4m
Kittathum Nguansamarng	Chief of HR and IT & Director	no data	データなし	5.73% THB 69.0m
Taveesak Boonprasit	Chief Service Officer & Director	no data	データなし	5.78% THB 69.6m

2.6yrs

平均在職期間

経験豊富な経営陣: SMDの経営陣は経験豊富であると考えられます ( 2.6年の平均在職年数)。

SaintMed マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

SaintMed Public Company Limited, Annual General Meeting, Apr 26, 2024

Saintmed Public Company Limited Appoints Prapassorn Patamapinum as Chief Financial Officer

Less than half of directors are independent

Saintmed Public Company Limited Appoints Pipop Udorn as Members of Audit Committee

Less than half of directors are independent

Saintmed Public Company Limited Announces Chief Finance Officer Changes

Recent updates

New minor risk - Share price stability

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: ฿0.025 (vs ฿0.13 in 2Q 2023)

Now 20% undervalued after recent price drop

First quarter 2024 earnings released: ฿0.05 loss per share (vs ฿0.036 profit in 1Q 2023)

Upcoming dividend of ฿0.15 per share

Full year 2023 earnings released: EPS: ฿0.35 (vs ฿1.32 in FY 2022)

SaintMed Public Company Limited, Annual General Meeting, Apr 26, 2024

Investor sentiment improves as stock rises 27%

Upcoming dividend of ฿0.15 per share at 20% yield

Third quarter 2023 earnings released: EPS: ฿0.054 (vs ฿0.30 in 3Q 2022)

Saintmed Public Company Limited Announces Dividend for the Operating Period from 01 January 2023 to 30 September 2023, Payable on 13 December 2023

Saintmed Public Company Limited (SET:SMD) announces an Equity Buyback for 22,000,000 shares, representing 9.79% for THB 120 million.

Second quarter 2023 earnings released: EPS: ฿0.13 (vs ฿0.39 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.036 (vs ฿0.61 in 1Q 2022)

Saintmed Public Company Limited Approves Dividend for the Year 2022, Payable on May 19, 2023

Upcoming dividend of ฿0.50 per share at 14% yield

Third quarter 2022 earnings released: EPS: ฿0.30 (vs ฿0.85 in 3Q 2021)

Saintmed Public Company Limited Appoints Prapassorn Patamapinum as Chief Financial Officer

Less than half of directors are independent

Upcoming dividend of ฿0.25 per share

Second quarter 2022 earnings released: EPS: ฿0.39 (vs ฿0.38 in 2Q 2021)

Saintmed Public Company Limited Announces Dividend for the Operating Period from 01 January 2022 to 30 June 2022, Payable on 14 September 2022

Saintmed Public Company Limited Appoints Pipop Udorn as Members of Audit Committee

First quarter 2022 earnings released: EPS: ฿0.64 (vs ฿0.048 in 1Q 2021)

Less than half of directors are independent

Saintmed Public Company Limited Announces Chief Finance Officer Changes

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Saintmed Public Company Limited, Annual General Meeting, Apr 26, 2022

Third quarter 2021 earnings released: EPS ฿0.89 (vs ฿0.069 in 3Q 2020)

Second quarter 2021 earnings released: EPS ฿0.39 (vs ฿0.069 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ฿0.05 (vs ฿0.98 in 1Q 2020)

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

マネジメント基準チェック /14